Skip to Content
Who We Are
Leadership

Demiana Faltaos, Pharm.D., Ph.D.

Vice President, Clinical Pharmacology

Demiana leads Parabilis Medicines’ clinical pharmacology efforts, advancing drug development and improving patient outcomes by ensuring the highest standards of safety and efficacy. With over 20 years of experience in research, clinical development, and pharmacometrics, Demiana brings significant expertise from her previous role as Vice President, Head of Clinical Pharmacology at Olema Oncology. She has managed complex drug development programs and has extensive experience with regulatory submissions across diverse therapeutic areas, particularly in oncology. Notable projects include Invega®, Invega Sustenna®, Risperdal Consta®, Byetta®, Bydureon®, Myalept®, Mocetinostat, Glesatinib, Sitravatinib, Krazati®, and Palazestrant.

Demiana holds a Ph.D. in Pharmacokinetics and Drug Metabolism from René Descartes University of Paris V and has completed executive development programs at Northwestern University’s Kellogg School of Management.

Back to Team